UniSuper Management Pty Ltd Acquires 2,884 Shares of Teleflex Incorporated (NYSE:TFX)

UniSuper Management Pty Ltd raised its stake in shares of Teleflex Incorporated (NYSE:TFX) by 41.6% in the 4th quarter, Holdings Channel reports. The firm owned 9,824 shares of the medical technology company’s stock after purchasing an additional 2,884 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Teleflex were worth $1,748,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. True Wealth Design LLC raised its position in shares of Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after acquiring an additional 166 shares during the last quarter. Avior Wealth Management LLC lifted its position in shares of Teleflex by 81.2% in the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company’s stock worth $50,000 after purchasing an additional 125 shares during the period. IFP Advisors Inc boosted its stake in shares of Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after purchasing an additional 217 shares during the last quarter. Exchange Traded Concepts LLC increased its position in shares of Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after buying an additional 94 shares during the period. Finally, R Squared Ltd bought a new position in Teleflex during the fourth quarter worth $64,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Stock Down 1.2 %

Shares of NYSE TFX opened at $137.76 on Monday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The company has a 50-day moving average price of $159.20 and a 200-day moving average price of $189.98. The stock has a market capitalization of $6.39 billion, a P/E ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 1 year low of $128.55 and a 1 year high of $249.91.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, equities research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.99%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is currently 95.77%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on TFX. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. Piper Sandler reiterated a “neutral” rating and set a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Finally, Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and reduced their price target for the stock from $220.00 to $155.00 in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Teleflex presently has an average rating of “Hold” and a consensus price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.